Candida dubliniensis: Characteristics and identification

Journal of Clinical Microbiology

Volumn 36, Issue 2, 1998, Pages 329-334

  Sullivan, Derek ^a   Coleman, David ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CANDIDA; FUNGUS IDENTIFICATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MOUTH INFECTION; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY;

CANDIDA; CANDIDA DUBLINIENSIS; FUNGI; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0031985195     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.36.2.329-334.1998     Document Type: Short Survey

References (37)

1. Anthony, R. M., J. Midgley, S. P. Sweet, and S. A. Howell. 1995. Multiple strains of Candida albicans in the oral cavity of HIV-positive and HIV-negative patients. Microb. Ecol. Health Dis. 8:23-30.
2. Bennett, D. E., C. E. McCreary, and D. C. Coleman. 1998. Genetic characterization of a phospholipase C gene from Candida albicans: presence of homologous sequences in Candida species other than C. albicans. Microbiology 144:55-72.
3. Boerlin, P., F. Boerlin-Petzold, C. Durussel, M. Addo, J.-L. Pagani, J.-P. Chave, and J. Bille. 1995. Cluster of atypical Candida isolates in a group of human immunodeficiency virus-positive drug users. J. Clin. Microbiol. 33: 1129-1135.
4. Boucher, H., S. Mercure, S. Montplaisir, and G. Lemay. 1996. A novel group I intron in Candida dubliniensis is homologous to a Candida albicans intron. Gene 180:189-196.
5. Calvet, H. M., M. R. Yeaman, and S. G. Filler. 1997. Reversible fluconazole resistance in Candida albicans: a potential in vitro model. Antimicrob. Agents Chemother. 41:535-539.
6. Coleman, D., D. Sullivan, K. Haynes, M. Henman, D. Shanley, D. Bennett, G. Moran, C. McCreary, L. O'Neill, and B. Harrington. 1997. Molecular and phenotypic analysis of Candida dubliniensis: a recently identified species linked with oral candidosis in HIV-infected and AIDS patients. Oral Dis. 3(Suppl. 1):S96-S101.
7. Coleman, D. C., D. E. Bennett, P. J. Gallagher, S. R. Flint, A. Nolan, F. M. Mulcahy, D. J. Sullivan, M. C. Henman, R. J. Russell, and D. B. Shanley. 1995. Oral candidiasis and HIV infection: antifungal drug resistance and changes in Candida population dynamics, p. 112-118. In J. S. Greenspan and D. Greenspan (ed.), Oral manifestations of HIV infection. Quintessence Publishing Co., Ltd., Chicago, Ill.
8. Coleman, D. C., D. E. Bennett, D. J. Sullivan, P. J. Gallagher, M. C. Henman, D. B. Shanley, and R. J. Russell. 1993. Oral Candida in HIV infection and AIDS: new perspectives new approaches. Crit. Rev. Microbiol. 19:61-82.
9. Coleman, D. C., D. J. Sullivan, D. E. Bennett, G. P. Moran, H. J. Barry and D. B. Shanley. 1997. Candidiasis: the emergence of a novel species, Candida dubliniensis. AIDS 11:557-567.
10. Fridkin, S. K., and W. R. Jarvis. 1996. Epidemiology of nosocomial fungal infections. Clin. Microbiol. Rev. 9:499-511.
11. Hazen, K. C. 1995. New and emerging yeast pathogens. Clin. Microbiol. Rev. 8:462-478.
12. Jarvis, W. R. 1995. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin. Infect. Dis. 20:1526-1530.
13. Joly, S., and D. R. Soll. 1997. Personal communication.
14. Kurtzman, C. P., and C. J. Robnett. 1997. Identification of clinically important ascomycetous yeasts based on nucleotide divergence in the 5′ end of the large-subunit (26S) ribosomal DNA gene. J. Clin. Microbiol. 35:1216-1223.
15. Kwon-Chung, K. J., W. S. Riggsby, R. A. Uphoff, J. B. Hicks, W. L. Whelan, E. Reiss, B. B. Magee, and B. L. Wickes. 1989. Genetic differences between type I and type II Candida stellatoidea. Infect. Immun. 57:527-532.
16. Le Guennec, R., J. Reynes, M. Mallié. C. Pujol, F. Janbon, and J.-M. Bastide. 1995. Fluconazole- and intraconazole-resistant Candida albicans strains from AIDS patients: multilocus enzyme electrophoresis analysis and antifungal susceptibilities. J. Clin. Microbiol. 33:2732-2737.
17. McCullough, M., B. Ross, and P. Reade. 1995. Characterization of genetically distinct subgroup of Candida albicans strains isolated from oral cavities of patients infected with human immunodeficiency virus. J. Clin. Microbiol. 33:696-700.
18. McCullough, M. J., B. C. Ross, B. D. Dwyer, and P. C. Reade. 1944. Genotype and phenotype of oral Candida albicans from patients infected with the human immunodeficiency virus. Microbiology 140:1195-1202.
19. Mercure, S., S. Senechal, P. Auger, G. Lemay, and S. Montplaisir. 1996. Candida albicans serotype analysis by flow cytometry. J. Clin. Microbiol. 34:2106-2112.
20. Meyer, S. A., D. G. Ahearn, and D. Yarrow. 1984. Genus 4. Candida Berkhout, p. 585-844. In N. J. W. Kreger van Rij (ed.), The yeasts: a taxonomic study. Elsevier, Amslerdam, The Netherlands.
21. Moran, G. P., D. J. Sullivan, M. C. Henman, C. E. McCreary, B. J. Harrington, D. B. Shanley, and D. C. Coleman. 1997. Antifungal drug susceptibility of oral Candida dubliniensis isolates from HIV-infected and non-HIV-infecled subjects and generation of stable fluconazole-resistant derivatives in vitro. Antimicrob. Agents Chemother. 41:617-623.
22. Odds, F. C., and R. Bernaerts. 1944. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J. Clin. Microhiol. 32:1923-1929.
23. Odds, F. C., J. Schmid, and D. R. Soll. 1990. Epidemiology of Candida infection in AIDS, p. 67-74. In H. Vanden Bossche et al. (ed.), Mycoses in AIDS patients. Plenum Press, New York, N.Y.
24. Olsen, G. J., and C. R. Woese. 1993. Rihosomal RNA: a key to phylogeny. FASEB J. 7:113-123.
25. Peterson, S. W., and C. P. Kurtzman. 1991. Ribosomal RNA sequence divergence among sibling species of yeasts. Syst. Appl. Microbiol. 14:124-129.
26. Pfaller, M. A. 1996. Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission. Clin Infect. Dis. 22(Suppl. 2):S89-S94.
27. Pujol, C., F. Renaud, M. Mallié, T. de Meeûs, and J.-M. Bastide. 1997. Atypical strains of Candida albicans recovered from AIDS patients. J. Med. Vet. Mycol. 35:115-121.
28. Samaranayake, L. P. 1992. Oral mycoses in HIV infection. Oral Surg. Oral Med. Oral Pathol. 73:171-180.
29. Schmid, J., F. C Odds, M. J. Wiselka, K. G. Nicholson, and D. R. Soll. 1992. Genetic similarity and maintenance of Candida albicans strains from a group of AIDS patients, demonstrated by DNA fingerprinting. J. Clin. Microbiol. 30:935-941.
30. Schoofs, A., F. C. Odds, R. Colebunders, M. Ieven, and H. Goosens. 1997. Use of specialised isolation media for recognition and identification of Candida dubliniensis isolates from HIV-infected patients. Eur. J. Clin. Infect. Dis. 16:296-300.
31. Sullivan, D., D. Bennett, M. Henman, P. Harwood, S. Flint, F. Mulcahy, D. Shanley, and D. Coleman. 1993. Oligonucleotide fingerprinting of isolates of Candida species other than C. albicans and of atypical Candida species from human immunodeficiency virus-positive and AIDS patients. J. Clin. Microbiol. 31:2124-2133.
32. Sullivan, D., and D. Coleman. Unpublished data.
33. Sullivan, D. J., K. Haynes, J. Bille, P. Boerlin, L. Rodero, S. Lloyd, M. Henman, and D. Coleman. 1997. Widespread geographic distribution of oral Candida dubliniensis strains in human immunodeficiency virus-infected individuals. J. Clin. Microbiol. 35:960-964.
34. Sullivan, D. J., M. C. Henman, G. P. Moran, L. C. O'Neill, D. E. Bennett, D. B. Shanley, and D. C. Coleman. 1996. Molecular genetic approaches to identification, epidemiology and taxonomy of non-albicans Candida species. J. Med. Microbiol. 44:399-408.
35. Sullivan, D. J., T. J. Westerneng, K. A. Haynes, D. E. Bennett, and D. C. Coleman. 1995. Candida dubliniensis sp. nov.: phenotypic and molecular characterisation of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology 141:1507-1521.
36. Wickes, B. L., and R. Petter. 1996. Genomic variation in Candida albicans. Curr. Top. Med. Mycol. 7:71-86.
37. Wingard, J. R. 1995. Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin. Infect. Dis. 20:115-125.